Results 1 to 10 of about 672,953 (296)

Semaglutide in Overweight and Obese patients: Cardiovascular and/or Renal Metabolic Benefits

Revista Colombiana de Nefrología, 2022
We have read the article published by Kadowaki, et al. 1 “Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes mellitus in an East Asian population (STEP 6): A randomized, double blind, double dummy, placebo ...
Jorge Rico-Fontalvo, Rodrigo Daza-Arnedo, Jose Cabrales, Juan Diego Montejo-Hernández   +3 more
doaj   +1 more source

Additional Considerations in the Treatment of Diabetic Nephropathy Based on the KDOQI Clinical Practice Guideline

Revista Colombiana de Nefrología, 2022
Obesity is a risk factor for the development and progression of CKD, which has been shown in numerous studies. The mechanism of how this occurs is not completely understood, but several putative mechanisms proposed via adiposity, include low adiponectin ...
Jorge Rico Fontalvo, Juan David Montejo Hernández, Rodrigo Daza Arnedo, Jose Cabrales   +3 more
doaj   +1 more source

Interactions between hypertension and inflammatory tone and the effect on blood pressure and outcomes in patients with COVID‐19

The Journal of Clinical Hypertension, 2021
Arterial hypertension represented one of the most common comorbidities in patients with COVID‐19. However, the impact of hypertension on outcome in COVID‐19 patients is not clear.
Jacques Amar, Nicolas Touront, Antoine M. Ciron, Caroline Pendaries   +3 more
doaj   +1 more source

Impact of concomitant COVID-19 on the outcome of patients with acute myocardial infarction undergoing coronary artery angiography

Frontiers in Cardiovascular Medicine, 2022
BackgroundThe impact of COVID-19 on the outcome of patients with MI has not been studied widely. We aimed to evaluate the relationship between concomitant COVID-19 and the clinical course of patients admitted due to acute myocardial infarction (MI ...
Michał Terlecki, Wiktoria Wojciechowska, Marek Klocek, Agnieszka Olszanecka, Adam Bednarski, Tomasz Drożdż, Christopher Pavlinec, Paweł Lis, Maciej Zając, Jakub Rusinek, Zbigniew Siudak, Stanisław Bartuś, Marek Rajzer   +12 more
doaj   +1 more source

Outcome in Elderly Patients with Anca – Associated Glomerulonephritis Managed with Immunosuppressive Treatment

Acta Clinica Croatica, 2021
The most common cause of rapidly progressive glomerulonephritis in elderly, antineutrophil cytoplasmic antibody-associated glomerulonephritis (ANCA-GN), demands immunosuppressive therapy (IS) regimen in a multi-morbid disease burdened population.
Karlo Kurtov, Mario Laganović, Sandra Karanović, Živka Dika, Ema Ivandić, Marijana Živko, Jelena Kos, Margareta Fištrek, Bojan Jelaković, Ivana Vuković Brinar   +9 more
doaj   +1 more source

Prevalence and clinical implications of atrial fibrillation in patients hospitalized due to COVID-19: Data from a registry in Poland

Frontiers in Cardiovascular Medicine, 2023
BackgroundAtrial fibrillation (AF) is a common arrhythmia with increasing prevalence with respect to age and comorbidities. AF may influence the prognosis in patients hospitalized with Coronavirus disease 2019 (COVID-19).
Michał Terlecki, Wiktoria Wojciechowska, Marek Klocek, Tomasz Drożdż, Maryla Kocowska-Trytko, Paweł Lis, Christopher Pavlinec, Jan W. Pęksa, Michał Kania, Zbigniew Siudak, Andrzej Januszewicz, Reinhold Kreutz, Maciej Małecki, Tomasz Grodzicki, Marek Rajzer, CraCov HHS Investigators   +15 more
doaj   +1 more source

Clinical phenotyping of plasma thrombospondin-2 reveals relationship to right ventricular structure and function in pulmonary hypertension

ERJ Open Research, 2023
Background Converging evidence from proteogenomic analyses prioritises thrombospondin-2 (TSP2) as a potential biomarker for idiopathic or heritable pulmonary arterial hypertension (PAH).
Anna M. Dittrich, Julia Mienert, Julian Pott, Lena Engels, Christoph Sinning, Jan K. Hennigs, Hans Klose, Lars Harbaum   +7 more
doaj   +1 more source

MicroRNA-483 amelioration of experimental pulmonary hypertension. [PDF]

, 2020
Endothelial dysfunction is critically involved in the pathogenesis of pulmonary arterial hypertension (PAH) and that exogenously administered microRNA may be of therapeutic benefit.
Bai, Liang, Chen, Shanshan, Chou, Chih-Hung, Cui, Xiaopei, Fan, Fenling, Gongol, Brendan, Gu, Mingxia, He, Ming, He, Yangyang, Huang, Hsien-Da, Jing, Zhi-Cheng, Lei, Yuyang, Li, Zhao, Malhotra, Atul, Miao, Yifei, Rabinovitch, Marlene, Shen, Yuan, Shyy, John Y-J, Wang, Xiaojian, Yan, Xiaosong, Zhang, Jiao, Zhang, Jin, Zhang, Yixin   +22 more
core   +1 more source

Resistant hypertension after renal infarction in a man with fibromuscular dysplasia

Blood Pressure, 2021
We report the case of 39-year-old Caucasian man presenting in emergency department with new onset of severe hypertension with hypokalaemia eight weeks after renal colic. Patient was referred to a hypertension unit for further investigation.
Nikolina Bukal, Dražen Perkov, Luka Penezić, Bojan Jelaković, Živka Dika   +4 more
doaj   +1 more source

Left main bronchus compression due to main pulmonary artery dilatation in pulmonary hypertension: two case reports [PDF]

, 2015
. Pulmonary arterial dilatation associated with pulmonary hypertension may result in significant compression of local structures. Left main coronary artery and left recurrent laryngeal nerve compression have been described.
Ariff, B, Davies, R, Gibbs, JS, Gin-Sing, W, Howard, L, Jaijee, SK, O'Regan, DP   +6 more
core   +1 more source